An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension.

John P HanrahanJelena P SeferovicJames D WakefieldPhebe J WilsonJennifer G ChickeringJoon JungKenneth E CarlsonDaniel P ZimmerAndrew L FrelingerAlan D MichelsonLinda MorrowMichael HallMark G CurrieG Todd MilneAlbert T Profy

Published in: Diabetologia (2019)

This trial was funded by Cyclerion Therapeutics.

Keyphrases

study protocol
placebo controlled
phase iii
phase ii
clinical trial
double blind
open label
randomized controlled trial
blood pressure
phase ii study
small molecule
arterial hypertension